{"url_path":"/sec/abt/8-k/2026-07-16/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-16","source_url":"https://www.sec.gov/Archives/edgar/data/1800/0001628280-26-048377-index.html","accession_number":"0001628280-26-048377","cik":"0000001800","ticker":"ABT","issuer_name":"ABBOTT LABORATORIES","edgar_url":"https://www.sec.gov/Archives/edgar/data/1800/0001628280-26-048377-index.html","primary_entity_key":"0000001800","primary_entity_name":"ABBOTT LABORATORIES"},"word_count":88,"has_tables":true,"body_markdown":"Item 9.01    Financial Statements and Exhibits\n\nExhibit No.Exhibit\n\n[99.1](abt-2026q2xexhibitx991.htm)\n\n[Press Release dated July 16, 2026 (furnished pursuant to Item 2.02).](abt-2026q2xexhibitx991.htm)\n\n104Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document).\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nABBOTT LABORATORIES\n\nDate: July 16, 2026By:/s/ Philip P. Boudreau\n\nPhilip P. Boudreau\n\nExecutive Vice President, Finance and Chief Financial Officer"}